This study aims to uncover the factors driving patient decisions regarding enrollment, withdrawal, or re-engagement in hidradenitis suppurativa clinical trials. Understanding these factors will significantly improve the relevance and effectiveness of future research endeavors.
Ultimately, this trial endeavors to deepen our understanding of the factors impacting hidradenitis suppurativa clinical trial participation. Enhancing participation rates could accelerate the development of innovative treatments for this debilitating condition.
Aged ≥ 18 years old
Diagnosis of hidradenitis suppurativa
Able to comprehend the investigational nature of the protocol and provide informed consent
Female patients who are currently pregnant or nursing
Inability to perform regular electronic reporting
Has known psychiatric or substance abuse disorders that would interfere with cooperation with the requirements of the trial.
Patients with hidradenitis suppurativa who are actively considering enrolling in a clinical study for said condition, but have not yet completed enrollment and randomization.
Case-crossover
Prospective
Not listed
Number of hidradenitis suppurativa patients who decide to enroll in a clinical research
Rate of hidradenitis suppurativa patients who remain in clinical trial to trial completion
Click on the lead sponsor to view all of their trials.
This trial is not recruiting at the moment. You can still explore other options:
